He is also a volunteer scientist at the National Institutes of Health, USA. His interest is in the application of systems biology approaches using proteomics, next-generation sequencing, bioinformatics, and advanced antibody technology to address unmet needs in clinical medicine, especially in the cutting edge treatment of cancer and autoimmune disease. His current projects include the development of personalized cancer vaccine, the generation of therapeutic monoclonal antibodies for cancer immunotherapy, and an initiative to sequence whole genomes of Thai population for delivering future precision medicine.